Percutaneous imaging-guided treatment of hydatid liver cysts: Do long-term results make it a first choice?

Kabaalioğlu, Adnan; Çeken, Kağan; Alimoğlu, Emel; Apaydın, Ali

doi:10.1016/j.ejrad.2006.01.014

Cited by 93 publications

(71 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite these limitations, our results are in accordance with previous reports showing that multivesiculated cysts (CE2 and CE3b) are prone to relapse, not only after albendazole but also after PAIR. 14,15 Our findings support the idea that CE3b cysts, although transitional from a clinical standpoint, should be considered active from a biological perspective. 2,4 Large cysts tend to have a much slower response to classical PAIR compared with small ones.…”

supporting

confidence: 79%

Efficacy and Safety of PAIR for Cystic Echinococcosis: Experience on a Large Series of Patients from Bulgaria

Golemanov¹,

Grigorov²,

Mitova³

et al. 2011

The American Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

We report our experience with puncture, aspiration, injection, and reaspiration (PAIR) for the treatment of cystic echinococcosis in Bulgaria. PAIR was performed in 230 patients with 348 echinococcal cysts. At 12-month follow-up, 77.6% of the cysts, all cystic echinococcosis (CE) 1 and CE3a cysts according to the World Health Organization Informal Working Group classification, showed various degrees of obliteration. In 11.5% of cysts, all of which were > 10 cm-type CE1, a significant amount of fluid persisted, and they were punctured again. Of those, 16 (4.6%) contained protoscolices and were treated by a second PAIR. The remaining 24 (6.9%) cysts were treated by simple aspiration or drainage. No significant reduction in size and no changes in the structure were observed in 10.9% of cysts, all of which were classified as CE2 or CE3b. Complications developed in 25.2% of patients, including severe anaphylactic reaction in two (0.9%) patients. Our experience confirms that PAIR is a successful first-choice treatment when a stage-specific approach is taken.

show abstract

supporting

confidence: 79%

Efficacy and Safety of PAIR for Cystic Echinococcosis: Experience on a Large Series of Patients from Bulgaria

Golemanov¹,

Grigorov²,

Mitova³

et al. 2011

The American Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

show abstract

“…26 Giorgio and others and Kabaalioglu and others reported repeated failures of PAIR in multivesiculated cysts (CE2 and CE3B). 27 These findings prompted most clinicians to use PAIR exclusively for unilocular cysts, with or without detached endocysts.…”

Section: Percutaneous Treatmentmentioning

confidence: 99%

RETRACTED: Management of liver hydatid cysts – Current perspectives

Anand

Rajagopalan

Mohan

2012

Medical Journal Armed Forces India

View full text Add to dashboard Cite

“…Percutaneous treatment of HLD was introduced in 1985 by Mueller et al and has become an alternative to surgery and medical therapy (29); it is now used worldwide after the introduction of PAIR and its modifications, such as PAIDS, percutaneous evacuation (PEVAC), and MoCaT. Mid-term and long-term results of percutaneous HLD treatment have been reported in the literature (4,(7)(8)(9)(10)19,22,23,30,31). The PAIR technique is used for CE1 and CE3a cysts smaller than 5 cm in diameter and is an outpatient procedure (5,(7)(8)(9)(10)17).…”

Section: Discussionmentioning

confidence: 99%

Percutaneous treatment of liver hydatid cysts in 190 patients: a retrospective study

et al. 2016

View full text Add to dashboard Cite

Background: Hydatid liver disease (HLD) is a significant health problem, especially in endemic areas worldwide. Percutaneous treatment is an effective alternative therapeutic option. Purpose: To present the clinical and radiological results of percutaneous treatment of HLD in 190 patients. Material and Methods: Percutaneous treatment of HLD between April 2005 and March 2015 was analyzed retrospectively. The demographic data, numbers and types of cysts, initial and final volumes of the cysts, types of percutaneous treatment, and procedure-related complications were determined. Results: A total of 190 patients (95 male patients and 95 female patients; age range, 5-82 years) with 283 liver hydatid cysts who underwent percutaneous treatment were included in the study. Of the 283 cysts, 234 (83%) were cystic echinococcosis CE1, 31 (11%) were CE3a, and 18 (6%) were CE2 cysts, according to the World Health Organization (WHO) classification. The percutaneous procedure was successful in all patients. A total of 12 (6.3%) major complications, including anaphylaxis, allergic skin reaction, perihepatic hemorrhage, and cavity infection, were seen. No mortality was noted. Recurrence in one patient and an additional cyst in one patient were seen. All patients were asymptomatic during the follow-up period. Mean volume reduction was 77.5%, with a mean follow-up period of 18 months. Conclusion: Percutaneous treatment is an effective and safe method for the treatment of HLD. It should be regarded as a first-line treatment method for uncomplicated hydatid cysts.

show abstract

Percutaneous imaging-guided treatment of hydatid liver cysts: Do long-term results make it a first choice?

Cited by 93 publications

References 26 publications

Efficacy and Safety of PAIR for Cystic Echinococcosis: Experience on a Large Series of Patients from Bulgaria

Efficacy and Safety of PAIR for Cystic Echinococcosis: Experience on a Large Series of Patients from Bulgaria

RETRACTED: Management of liver hydatid cysts – Current perspectives

Percutaneous treatment of liver hydatid cysts in 190 patients: a retrospective study

Contact Info

Product

Resources

About